Global Patent Index - EP 1086212 A2

EP 1086212 A2 20010328 - METHOD AND REAGENTS FOR THE TREATMENT OF DISEASES OR CONDITIONS RELATED TO MOLECULES INVOLVED IN ANGIOGENIC RESPONSES

Title (en)

METHOD AND REAGENTS FOR THE TREATMENT OF DISEASES OR CONDITIONS RELATED TO MOLECULES INVOLVED IN ANGIOGENIC RESPONSES

Title (de)

VERFAHREN UND WIRKSTOFFE ZUR BEHANDLUNG VON KRANKHEITEN UND ZUSTÄNDE DIE MIT ANGIOGENESE FAKTOREN ZUSAMMENHÄNGEN

Title (fr)

PROCEDE ET REACTIFS POUR LE TRAITEMENT DE MALADIES OU D'AFFECTIONS ASSOCIEES A DES MOLECULES IMPLIQUEES DANS LES REACTIONS ANGIOGENIQUES

Publication

EP 1086212 A2 20010328 (EN)

Application

EP 99915032 A 19990324

Priority

  • US 9906507 W 19990324
  • US 7967898 P 19980327

Abstract (en)

[origin: WO9950403A2] Nucleic acid molecule which modulates the synthesis, expression and/or stability of an mRNA encoding for angiogenic factors selected from aryl hydrocarbon nuclear transport (ARNT), intergrin subunit beta 3 ( beta 3), integrin subunit alpha 6 ( alpha 6) and tie - 2RNA. This invention further provides a treatment for indications related to angiogenesis using the nucleic acid molecules.

[origin: WO9950403A2] Nucleic acid molecule which modulate the synthesis, expression and/or stability of an mRNA encoding for angiogenic factors selected from aryl hydrocarbon nuclear transport (ARNT), intergrin subunit beta 3 ( beta 3), integrin subunit alpha 6 ( alpha 6) and tie - 2 RNA. This invention further provides a treatment for indications related to angiogenesis using the nucleic acid molecules.

IPC 1-7

C12N 15/00; C07K 14/47; C12N 9/00

IPC 8 full level

A61K 31/7088 (2006.01); A61K 31/7125 (2006.01); A61K 35/76 (2006.01); A61K 48/00 (2006.01); A61P 3/10 (2006.01); A61P 17/06 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C12N 5/10 (2006.01); C12N 9/00 (2006.01); C12N 15/09 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 38/00 (2006.01)

CPC (source: EP)

A61P 3/10 (2017.12); A61P 17/06 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C12N 15/113 (2013.01); C12N 15/1138 (2013.01); A61K 38/00 (2013.01); C12N 2310/111 (2013.01); C12N 2310/12 (2013.01); C12N 2310/121 (2013.01); C12N 2310/122 (2013.01); C12N 2310/124 (2013.01); C12N 2310/126 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/33 (2013.01)

Citation (search report)

See references of WO 9950403A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9950403 A2 19991007; WO 9950403 A3 20010118; WO 9950403 A9 20000316; AU 3364799 A 19991018; AU 757789 B2 20030306; CA 2324421 A1 19991007; EP 1086212 A2 20010328; JP 2002509721 A 20020402

DOCDB simple family (application)

US 9906507 W 19990324; AU 3364799 A 19990324; CA 2324421 A 19990324; EP 99915032 A 19990324; JP 2000541291 A 19990324